InvestorsHub Logo
Followers 17
Posts 2713
Boards Moderated 0
Alias Born 04/30/2011

Re: TPX post# 8179

Monday, 08/01/2016 9:14:35 AM

Monday, August 01, 2016 9:14:35 AM

Post# of 18649
Too bad that OXS-1550 is a bi-specific antibody and not really an immunotherapy.

"Now, as yet, there’s no proof that the TrIKE tech can combine with OXS-1550 (this is speculative on our part) but that the company is working with UoM on the technology suggests that this is their end-goal. "
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent GTBP News